Chronotherapeutic Dose Schedule of Phenytoin and Carbamazepine in Epileptic Patients

References

• Bellamy N., Sothern RB., Campbell J. Rhythmic variation in pain perception in osteoarthritis of the knee. J. Rheumatol. 1990; 17: 364–372
   PubMed Web of Science ®Google Scholar
• Bruguerolle B., Valli M., Bouyard L., Jadot G., Bouyard P. Circadian effect on carbamazepine kinetics in rat. Eur. J. Drug Metab. Pharmacokinet. 1981; 6: 189–193
   PubMedGoogle Scholar
• Buchital F., Lennon V., Buchtal M. A. Diphenyl hydantoin relation of anticonvulsant effect to concentration in serum. Antiepileptic Drugs, D. M. Woodbury, J. K. Piery. Raven Press, New York 1972; 193–198
   Google Scholar
• D'Alonzo G. E., Crocetti J. G., Smolensky M. H. Circadian rhythms in the pharmacokinetics & clinical effects of beta agonist, theophylline and anticholinergic in the treatment of nocturnal asthma. Chronobiol. Int. 1999; 16: 663–682
   PubMed Web of Science ®Google Scholar
• Dreifuss F. E., Bancaud J., Henriksen O. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981; 22: 489–501
   PubMed Web of Science ®Google Scholar
• Eadie M. J. Therapeutic drug monitoring—antiepileptic drugs. Brit. J. Clin. Pharmacology 1998; 46: 185–193
   PubMed Web of Science ®Google Scholar
• Gerson B., Frances B. D., Sum C., Broussard L., Stearns F. C. Control of epilepsy. Clin. Chem. 1984; 30: 105–108
   PubMed Web of Science ®Google Scholar
• Goldenheim P. D., Conrad E. A., Schein L. Treatment of asthma by a controlled release theophylline tablet formulation: a review of the North American clinical experience with nocturnal dosing. Chronobiol. Int. 1987; 4: 397–408
   PubMed Web of Science ®Google Scholar
• Haim A., Shanas U., Zubidad A. S., Scantelbury M. Seasonality and seasons out of time—the thermoregulatory effects of light interference. Chronobiol. Int. 2005; 22: 59–66
   PubMed Web of Science ®Google Scholar
• Herkes G. K. Antiepileptics; clinical application. Australian Prescriber 1994; 17(1)9–12
   Google Scholar
• Hermida R. C., Smolensky M. H. Chronotherapy of hypertension. Curr. Opin. Nephrol. Hypertens. 2004; 13: 501–505
   PubMed Web of Science ®Google Scholar
• Ireland A., Colin James D. G., Gear P., Golding P. L., Ramage J. K., Williams R. G., Leicester R. J., Smith C. L., Ross G., Bamforth J. Ranitidine 150 mg twice daily vs. 300 mg nightly in treatment of duodenal ulcers. Lancet 1984; 2: 274–276
   PubMed Web of Science ®Google Scholar
• Joshi M. V., Pohujani S. M., Jain S. K., Kshirsagar N. A., Shah P. O., Acharya V. N. Phenytoin dose adjustments in Indian population. Neurology India 1990; 38: 339–342
   Google Scholar
• Kowanko J. C., Powall R., Knapp M. S., Swannell A. J. Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day. Br. J. Clin. Pharmacol 1981; 11: 477–484
   PubMed Web of Science ®Google Scholar
• Kutt H., Winters W., Kobenge R., McDowell T. Diphenyl hydantoin, metabolism, blood levels and toxicity. Arch. Neurol. 1964; 11: 642–648
   PubMed Web of Science ®Google Scholar
• Labrecque G., Reinberg A. E. Chronopharmacology of nonsteroidal antiinflammatory drugs. Chronopharmacology Cellular and Biochemical Interactions, B. Lemmer. Marcel Dekker, NewYork 1989; 545–579
   Google Scholar
• Langdon‐Down M., Brain W. R. Time of day in relation to convulsions in epilepsy. Lancet 1929; 1: 1029–1032
   Google Scholar
• Lusteffes M., Jolley M., Pittlock G., Panas H. Fluorescence polarisation immunoassay of phenytoin and phenobarbital. Clin. Chem 1981; 27: 1093, (Abstract)
   Web of Science ®Google Scholar
• Manfredini R., Boari B., Smolensky M. H., Salmi R., Gallerani M., Guerzoni F., Guerra V., Maria M. A., Manfredini F. Seasonal variation in onset of myocardial infarction—a seven‐year single‐center study in Italy. Chronobiol. Int. 2005; 22: 1121–1135
   PubMed Web of Science ®Google Scholar
• McNamara J. O. Pharmacotherapy of the epilepsies. Goodman & Gilman's the Pharmacological Basis of Therapeutics11th ed., L. L. Brunton, J. S. Lazo, K. L. Parker. McGraw‐Hill Publications, New York 2006; 501–525
   Google Scholar
• Penry J. K., Newmark M. G. The use of antiepileptic drug. Arch. Intern. Med. 1979; 90: 207–218
   Google Scholar
• Pisani F., Oteri G., Capute M., Perrir D. Chronopharmacology in Therapy of the Epilepsies. Raven Press, New York 1990; 129–142
   Google Scholar
• Portaluppi F., Manfredini R., Fersini C. From a static to a dynamic concept of risk: a circadian epidemiology of cardiovascular risk. Chronobiol. Int. 1999; 16: 33–50
   PubMed Web of Science ®Google Scholar
• Quigg M. Circadian rhythms: interactions with seizures and epilepsy. Epilepsy Res. 2000; 42: 43–55
   PubMed Web of Science ®Google Scholar
• Reinberg A. Concepts in chronopharmacology. Ann. Rev. Pharmacol. Toxicol. 1992; 32: 51–66
   PubMed Web of Science ®Google Scholar
• Reinberg A., Smolensky M. H. Circadian changes of drug disposition in man. Clin. Pharmacokinet. 1982; 7: 401–420
   PubMed Web of Science ®Google Scholar
• Reinberg A., Gervais P., Chaussade M., Fraboulet G., Duburque B. Circadian changes in effectiveness of corticosteroids in eight patients with allergic asthma. J. Allergy Clin. Immunol. 1983; 71: 425–433
   PubMed Web of Science ®Google Scholar
• Smolensky M. H. Chronobiolgy and chronotherapeutics applications to cardiovascular medicines. Amer. J. Hypertens. 1986; 11S–21S, (4 pt 3)
   Google Scholar
• Smolensky M. H., D'Alonzo G. E. Medical chronobiology: concepts and applications. Ann. Rev. Respir. Dis. 1993; 147: S2–S19
   Google Scholar
• Touitou Y., Portaluppi F., Smolensky M. H., Rensing L. Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol. Int. 2004; 21: 161–170
   PubMed Web of Science ®Google Scholar
• White W. B., Black H. R., Weber M. A. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate‐blood pressure product. Am. J. Cardio. 1998; 81: 421–431
   Web of Science ®Google Scholar
• Yegnanarayan R., Balwani J. H. Circadian variation in high blood pressure lowering effects of clonidine and alpha methyl dopa. Biol. Rhythm Res. 1994; 25: 329–340
   Web of Science ®Google Scholar
• Yegnanarayan R., Kulkarni H. G., Wadia R. W. The effect of time of administration of Phenytoin on its serum levels and pharmacodynamic parameters in patients of generalised tonic‐clonic seizures. Biol. Rhythm Res. 1999; 30: 321–331
   Web of Science ®Google Scholar